Added to YB: 2023-08-02
Pitch date: 2023-08-02
ADCT:US [bullish]
ADC Therapeutics SA
-20.13%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States.
Market Cap
$151.4M
Pitch Price
$1.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.53
P/E
-1.10
EV/Sales
4.50
Sector
Biotechnology
Category
N/A
Show full summary:
ADC Therapeutics Ltd ADCT:US
A summary for this pitch has not been created yet.
Read full article (0 min)